Sanitar Co., Ltd. (TPE:1817)
38.70
-0.05 (-0.13%)
At close: Mar 26, 2026
Sanitar Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,601 | 2,770 | 2,481 | 2,652 | 2,358 |
Other Revenue | 17.47 | 20.2 | 19.59 | 17.44 | 14.98 |
| 2,618 | 2,790 | 2,501 | 2,670 | 2,373 | |
Revenue Growth (YoY) | -6.17% | 11.58% | -6.32% | 12.52% | 2.87% |
Cost of Revenue | 1,654 | 1,801 | 1,643 | 1,750 | 1,575 |
Gross Profit | 964.13 | 989.48 | 857.62 | 919.34 | 797.55 |
Selling, General & Admin | 573 | 575.77 | 535.16 | 518.69 | 483.14 |
Research & Development | 34.02 | 37.89 | 35.19 | 28.61 | 22.83 |
Other Operating Expenses | - | - | - | - | 0.11 |
Operating Expenses | 639.48 | 616.96 | 569.01 | 546.72 | 510.32 |
Operating Income | 324.66 | 372.52 | 288.61 | 372.63 | 287.23 |
Interest Expense | -5.09 | -5.11 | -5.88 | -7.72 | -7.07 |
Interest & Investment Income | 14.44 | 10.67 | 7.56 | 4.35 | 3.73 |
Currency Exchange Gain (Loss) | - | 15.53 | 8.86 | 9.82 | 3.97 |
Other Non Operating Income (Expenses) | 20.31 | 0.89 | 2.9 | 1.47 | 2.11 |
EBT Excluding Unusual Items | 354.32 | 394.51 | 302.04 | 380.54 | 289.97 |
Gain (Loss) on Sale of Investments | - | 12.87 | 4.6 | 2.5 | -3.18 |
Gain (Loss) on Sale of Assets | - | 1.01 | 1.62 | 0.39 | 0.92 |
Other Unusual Items | - | 0.17 | - | - | - |
Pretax Income | 354.32 | 408.55 | 308.26 | 383.43 | 287.71 |
Income Tax Expense | 90.84 | 87.44 | 70.8 | 88.14 | 62.86 |
Earnings From Continuing Operations | 263.48 | 321.11 | 237.46 | 295.29 | 224.85 |
Minority Interest in Earnings | -1.27 | -5.88 | -1.82 | -4.46 | -3.48 |
Net Income | 262.21 | 315.23 | 235.64 | 290.83 | 221.37 |
Net Income to Common | 262.21 | 315.23 | 235.64 | 290.83 | 221.37 |
Net Income Growth | -16.82% | 33.78% | -18.98% | 31.38% | 0.58% |
Shares Outstanding (Basic) | 73 | 72 | 72 | 72 | 72 |
Shares Outstanding (Diluted) | 73 | 73 | 73 | 73 | 72 |
Shares Change (YoY) | 0.38% | 0.27% | -0.06% | 0.35% | -0.43% |
EPS (Basic) | 3.61 | 4.37 | 3.27 | 4.04 | 3.07 |
EPS (Diluted) | 3.59 | 4.33 | 3.25 | 4.01 | 3.06 |
EPS Growth | -17.09% | 33.23% | -18.95% | 31.05% | 0.99% |
Free Cash Flow | 423.98 | 252.18 | 303.25 | 334.37 | 216.22 |
Free Cash Flow Per Share | 5.80 | 3.47 | 4.18 | 4.61 | 2.99 |
Dividend Per Share | - | 2.400 | 1.800 | 2.300 | 2.000 |
Dividend Growth | - | 33.33% | -21.74% | 15.00% | - |
Gross Margin | 36.82% | 35.46% | 34.29% | 34.44% | 33.62% |
Operating Margin | 12.40% | 13.35% | 11.54% | 13.96% | 12.11% |
Profit Margin | 10.02% | 11.30% | 9.42% | 10.89% | 9.33% |
Free Cash Flow Margin | 16.19% | 9.04% | 12.13% | 12.53% | 9.11% |
EBITDA | 422.62 | 455.6 | 375.22 | 462.99 | 375.72 |
EBITDA Margin | 16.14% | 16.33% | 15.00% | 17.34% | 15.84% |
D&A For EBITDA | 97.97 | 83.07 | 86.61 | 90.37 | 88.5 |
EBIT | 324.66 | 372.52 | 288.61 | 372.63 | 287.23 |
EBIT Margin | 12.40% | 13.35% | 11.54% | 13.96% | 12.11% |
Effective Tax Rate | 25.64% | 21.40% | 22.97% | 22.99% | 21.85% |
Revenue as Reported | 2,618 | 2,790 | 2,501 | 2,670 | 2,373 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.